Commonwealth Equity Services’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $689K | Buy |
+20,823
| New | +$882K | ﹤0.01% | 2923 |
|
|
2024
Q4 | – | Sell |
-5,328
| Closed | -$206K | – | 4116 |
|
|
2024
Q3 | $206K | Buy |
+5,328
| New | +$190K | ﹤0.01% | 3669 |
|
|
2024
Q2 | – | Sell |
-5,153
| Closed | -$200K | – | 4069 |
|
|
2024
Q1 | $200K | Buy |
+5,153
| New | +$180K | ﹤0.01% | 3628 |
|
|
2023
Q2 | – | Sell |
-17,652
| Closed | -$423 | – | 3852 |
|
|
2023
Q1 | $423 | Buy |
+17,652
| New | +$468K | ﹤0.01% | 2695 |
|
|
2020
Q4 | – | Sell |
-9,827
| Closed | -$204K | – | 3211 |
|
|
2020
Q3 | $204K | Buy |
+9,827
| New | +$177K | ﹤0.01% | 2702 |
|
|
2020
Q1 | – | Sell |
-28,127
| Closed | -$578K | – | 2841 |
|
|
2019
Q4 | $578K | Buy |
28,127
+600
| +2% | +$10K | ﹤0.01% | 1794 |
|
|
2019
Q3 | $316K | Hold |
27,527
| – | – | ﹤0.01% | 2192 |
|
|
2019
Q2 | $361K | Hold |
27,527
| – | – | ﹤0.01% | 2054 |
|
|
2019
Q1 | $416K | Sell |
27,527
-559
| -2% | -$8.95K | ﹤0.01% | 1901 |
|
|
2018
Q4 | $482K | Sell |
28,086
-750
| -3% | -$12.8K | ﹤0.01% | 1675 |
|
|
2018
Q3 | $425K | Sell |
28,836
-703
| -2% | -$12.5K | ﹤0.01% | 1893 |
|
|
2018
Q2 | $705K | Buy |
29,539
+5,640
| +24% | +$139K | ﹤0.01% | 1504 |
|
|
2018
Q1 | $610K | Sell |
23,899
-1,651
| -6% | -$39.3K | ﹤0.01% | 1574 |
|
|
2017
Q4 | $472K | Buy |
25,550
+4,750
| +23% | +$68K | ﹤0.01% | 1731 |
|
|
2017
Q3 | $218K | Sell |
20,800
-90
| -0.4% | -$992 | ﹤0.01% | 2208 |
|
|
2017
Q2 | $261K | Buy |
20,890
+2,499
| +14% | +$24.7K | ﹤0.01% | 2020 |
|
|
2017
Q1 | $185K | Buy |
+18,391
| New | +$273K | ﹤0.01% | 2173 |
|
Other funds holding COLL
EAM
VCM
